Contemporary surgical outcome for skull base meningiomas

Neurosurg Rev. 2011 Jul;34(3):281-96; discussion 296. doi: 10.1007/s10143-011-0321-x. Epub 2011 May 26.

Abstract

Although surgical excision of meningioma and its dural base is the most common primary management, skull base meningiomas are quite different, and contemporary management usually consists of multimodal treatment with the aim of achieving the best possible functional outcome and quality of life (QOL) for these patients. As surgery plays an important role in the treatment of skull base meningiomas, it is crucial for neurosurgeons to appreciate the surgical outcome and QOL after meningioma surgery. Outcome is usually measured for meningiomas in terms of morbidity, mortality, time to recurrence, and QOL. The extent of resection, tumor grade, proliferative markers, and tumor location are significant factors in predicting the surgical outcome. Therefore, we address each of these factors in detail in this review. Advances in recent decades in microsurgical techniques, neuroimaging modalities, neuroanesthesia, and perioperative intensive care have substantially improved the surgical outcome; therefore, most surgical outcomes discussed in this review are cited from contemporary literature (2000 to the present) in order to depict the surgical outcome of contemporary microsurgery.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor
  • Humans
  • Meningioma / pathology
  • Meningioma / radiotherapy
  • Meningioma / surgery*
  • Predictive Value of Tests
  • Quality of Life
  • Radiosurgery
  • Skull Base Neoplasms / pathology
  • Skull Base Neoplasms / radiotherapy
  • Skull Base Neoplasms / surgery*
  • Treatment Outcome

Substances

  • Biomarkers, Tumor